Reproducibility of late gadolinium enhancement quantification techniques in ischemic and non-ischemic heart diseases (ReLate study)
Frontiers in Cardiovascular Medicine · 01.08.2025 · 12
DOI: 10.3389/fcvm.2025.1621292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 01.08.2025. Verfasst von Jonathan Gavrysh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Working Group on CMR, Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholt…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance (CMR) is an established metric for risk stratification and therapeutic guidance. However, consensus on the optimal technique for quantifying left ventricular (LV) LGE extent remains lacking. This study aimed to identify the most reliable method for quantifying LGE in chronic myocardial infarction (CMI), hypertrophic cardiomyopathy (HCM), and inflammatory heart disease (IHD).
Methods
A retrospective analysis was conducted on 285 prospectively enrolled patients (CMI: n = 98; HCM: n = 91; IHD: n = 96). LV LGE images in short-axis orientation were analyzed twice by the same reader. The most reliable LGE quantification technique was defined as the one achieving the highest intra-observer reproducibility. A two-step study design was implemented: in the pilot phase ( n = 90), three quantification methods were compared: full width at half maximum (FWHM), signal threshold vs. reference mean using 2–6 standard deviations (n-SD), and manual thresholding. Techniques demonstrating the lowest variability were then applied in a validation cohort ( n = 195). A mixed model for repeated measures was used to estimate mean differences. Equivalence was confirmed if the 95% confidence interval (CI) for the mean difference remained within predefined margins.
Results
In CMI, FWHM demonstrated the highest reproducibility, with a mean difference of 0.47% (95% CI: −0.40 to 1.35). In HCM, both the 5-SD and 6-SD techniques showed the highest reproducibility, with mean differences of 0.06% (95% CI: −1.28 to 1.39) and −0.16% (95% CI: −1.50 to 1.17), respectively. In IHD, the 5-SD and 6-SD techniques achieved the highest reproducibility, with mean differences of −0.72% (95% CI: −1.54 to 0.11) and −0.71% (95% CI: −1.54 to 0.11).
Conclusion
The distribution and pattern of LGE influence the reproducibility of its quantification. FWHM provided the highest intra-observer reproducibility for sharply demarcated scars, as seen in CMI. For more diffuse fibrosis patterns, such as in HCM and IHD, both the 5-SD and 6-SD techniques offered similarly reproducible performance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Working Group on CMR, Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
- Department of Cardiology and Nephrology, HELIOS Hospital Berlin-Buch, Berlin, Germany.
- Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany.
- KIZ-Kardiologie im Zentrum and Ludwig-Maximilians-University Munich, Munich, Germany.
Zitieren
APA
Gavrysh, J., Reisdorf, P., Hadler, T., Mayr, T., Ammann, C., Gröschel, J., Kuhnt, J., von Knobelsdorff-Brenkenhoff, F., Muehlberg, F., Schwenke, C., Fenski, M., & Schulz-Menger, J. (2025). Reproducibility of late gadolinium enhancement quantification techniques in ischemic and non-ischemic heart diseases (ReLate study). Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1621292
Vancouver
Gavrysh J, Reisdorf P, Hadler T, Mayr T, Ammann C, Gröschel J, et al. Reproducibility of late gadolinium enhancement quantification techniques in ischemic and non-ischemic heart diseases (ReLate study). Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1621292
BibTeX
@article{Gavrysh2025,
author = {Gavrysh, Jonathan and Reisdorf, Philine and Hadler, Thomas and Mayr, Thomas and Ammann, Clemens and Gröschel, Jan and Kuhnt, Johanna and von Knobelsdorff-Brenkenhoff, Florian and Muehlberg, Fabian and Schwenke, Carsten and Fenski, Maximilian and Schulz-Menger, Jeanette},
title = {Reproducibility of late gadolinium enhancement quantification techniques in ischemic and non-ischemic heart diseases (ReLate study)},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1621292}
}
EUVIMED